SEC Comment Letter for Korro Bio, Inc. (KRRO) (CIK 0001703647) (KRRO) — Dec 6, 2024
Korro Bio, Inc. (KRRO) (CIK 0001703647)
Date: Dec. 6, 2024 · CIK: 0001703647 · Accession: 0000000000-24-013468
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283552
Letter
December 6, 2024 Ram Aiyar President and Chief Executive Officer Korro Bio, Inc. 60 First Street, 2nd floor, Suite 250 Cambridge, MA 02141 Re:Korro Bio, Inc. Registration Statement on Form S-3 Filed December 2, 2024 File No. 333-283552 Dear Ram Aiyar: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Marianne Sarrazin, Esq.
Show Raw Text
December 6, 2024
Ram Aiyar
President and Chief Executive Officer
Korro Bio, Inc.
60 First Street, 2nd floor, Suite 250
Cambridge, MA 02141
Re:Korro Bio, Inc.
Registration Statement on Form S-3
Filed December 2, 2024
File No. 333-283552
Dear Ram Aiyar:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Marianne Sarrazin, Esq.